T-Rex 2X Inverse MSTR Daily Target ETF vs Procter & Gamble Co — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.6 (market cap $94.46M), while Procter & Gamble Co trades at $150.1 (market cap $349.77B). The key difference: Procter & Gamble Co is far larger — about 3702.8× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Procter & Gamble Co pays a 2.89% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Procter & Gamble Co for 131 Days on average.
| MSTZ | PG | |
|---|---|---|
Market Cap | $94.46M | $349.77B |
Volume | 104,717,733 | 10,055,825 |
Sector | Leveraged / Inverse | Consumer Staples |
52-Week High | $27.92 | $167.18 |
52-Week Low | $2.29 | $138.10 |
Typical Hold Time | 8 Days | 131 Days |
Enterprise Value | — | $375.61B |
Dividend Yield | — | 2.89% |
Signals from Pluang's Aura AI — not financial advice
MSTZ is currently trading at $2.66, showing strong daily momentum with a 13.43% gain. The technical picture remains bearish overall despite the recent price surge, with moving averages signaling continued downward pressure. Key financial ratios including P/E, P/S, and P/B are unavailable, limiting fundamental visibility. The stock faces significant resistance at the $3 level across multiple technical indicators.
The outlook remains cautious given the bearish technical signals and lack of transparent financial metrics. While the recent price surge indicates short-term momentum, investors face substantial uncertainty due to limited fundamental data availability. The primary risk involves the stock's inability to break through the $3 resistance zone, which could trigger renewed selling pressure.
Procter & Gamble (PG) trades at $147.82, down 0.4% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $1.88. Strong fundamentals include $84.28B revenue, 18.44% net margin, and robust cash flow generation. Recent developments include a WNBA partnership and a dividend declaration of $1.09 payable in August 2026.
PG offers stable growth with premium valuation metrics (P/E 22.33, P/S 4.11) supported by strong brand equity and dividend consistency. Risks include premium valuation concerns amid modest growth outlook and competitive pressures. Analyst consensus is bullish with a $160.13 price target, though near-term upside may be limited given current price proximity to the lower target range.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →